0
     

Report Added
Report already added
Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

[ 170 + Pages Research Report ] Europe Digital Therapeutics Market is anticipated to surpass USD 4 billion by 2030 from USD 0.5 billion in 2020 at a CAGR of 32% throughout the forecast period, i.e. 2020-2030

Product Overview

Digital therapeutic is a healthcare technology branch, which provides patients with applications and tools for the diagnosis, prevention, and treatment of medical diseases based on facts and evidence. Digital and online medical systems are used for the diagnosis of psychological and medical problems. Furthermore, software technologies enable patients and physicians to monitor patient data by tracking the conduct of patients. Digital therapy offers online supervision to resolve issues with long-term health. The European Chronic Diseases Alliance (ECDA) estimates that 85 percent of all fatalities are attributed to chronic illnesses such as heart disease, cancer, diabetes, severe lung disorders, and mental disorder in the European Union (EU). Moreover, the European economy spends about $130 billion a year on these chronic diseases. In comparison, digital therapy aims to reduce these costs. Digital therapies are anticipated to reduce the healthcare expenses of an insurance company by reducing the utilization of acute conditions plan in health insurance policies.

Market Highlights
Rise in smartphone usage, Europe's digital therapeutics market is predicted to grow rapidly during the forecast period of 2020-2030. Additionally, an increase in the cost of healthcare is projected to increase market growth to lower the costs and the prevalence of chronic diseases. More advanced devices associated with smartphones and related programs support the boost in the market.

Digital Therapeutics Market Expected Market Growth
Europe Digital Therapeutics Market

Digital Therapeutics Market: Segments
Due to the market opportunity, diabetes is anticipated to report the strongest growth

With the rise in the incidence and occurrence of diabetes, the highest growth is expected in this category in the forecast period. Patients with diabetes need appropriate treatment training to cope with symptoms such as polyuria, polydipsia, and polyphagia. Many clinicians use medicine and expect diabetes to hit the highest business value over the next five years. More than a quarter of the overall market share for 2018 was accounted for by the diabetes category.

The key consumers of in the European market are the patients in the end-use segment

Severely sick people need support and training to ensure their well-being and health. Hospitals are projected to expand at a fast rate as digital therapeutics technologies are being augmented to provide patients with accessible emergency care. Hospitals can help an individual’s access to health services and reduce the rising stress levels by utilizing mobile healthcare services.

Europe Digital Therapeutics Market

Market Dynamics
Drivers
Patient Care

It is guided to avoid, control, or treat a medical problem through software applications and devices. Software tools for the digital therapeutic sector may be used separately or in conjunction with devices, medicines, or any other treatment to ensure patient care and wellbeing effects. These services include digital technologies, best design practices, accessibility, and validation of clinics and data protection. Before using it, statutory bodies check and evaluate these goods. Digital therapeutics enable patients, healthcare professionals, and payers through high-quality, secure, and efficient data-driven treatments with sophisticated and usable resources to deal with a variety of ailments.

A rise in the adoption of technology

The expansion of the European digital therapeutics market is driven by an acceleration in acceptance and usage of smart devices like smartphones, tablets, and healthcare apps, the increment in the cost of healthcare management, and the spike in disease prevalence. In developing markets, high prospects of growth offer competitive opportunities for major players established in this region.


Restraint
Lack of Awareness

The lack of understanding of digital therapeutics and patient data protection issues in developing countries hinder the expansion of the industry. The government or private sector in most developing countries of Europe is not taking any major steps in boosting the digital therapeutics market due to a lack of awareness about these solutions. Cybersecurity poses a major threat to the databases, the hackers may hack the digital platforms and gain all the personal information related to the patients. Thus, the security and privacy issues of patients related to medical data hinder the market growth.

Europe Digital Therapeutics Market is further segmented by region into:

The U.K. Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Germany Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
France Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Italy Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Digital Therapeutics Market: Key Players
Johnson & Johnson Services, Inc.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Fitbit, Inc. (Twine Health, Inc.)
Medtronic Plc.
Novartis International AG (Pear Therapeutics, Inc.)
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Ada Health GmbH
Cognifit ltd
Caterina Vision GmbH
Sonormed GmbH
Kaia Health
Other Prominent Players
The Digital Therapeutics Market report also contains analysis on:
Digital Therapeutics Market Segments:

By Application
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others
By End-Use
Patients
Providers
Payers
Employers
Others
By Type
Software
Devices
Digital Therapeutics Market Dynamics
Digital Therapeutics Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Table of Contents

1. Executive Summary
2. Europe Digital Therapeutics
2.1. Europe Digital Therapeutics Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Recent Development, Policies & Regulatory Landscape
7. Risk Analysis
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. Europe Digital Therapeutics Industry Analysis
8.1. Porters Five Forces
8.1.1. Threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. Europe Digital Therapeutics Market
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. Europe Digital Therapeutics : Market Segmentation
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
10.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
10.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
10.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
10.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
10.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Application: Market Share (2020-2030F)
10.2.1. Diabetes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Obesity, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.3. CVD, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.4. CNS Disease Respiratory Diseases, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.5. Smoking Cessation, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By End Use: Market Share (2020-2030F)
10.3.1. Patients, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Providers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Payers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.4. Employers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.5. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4. By Type: Market Share (2020-2030F)
11. Company Profile
11.1. Johnson & Johnson Inc.,
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Fitbit, Inc. (Twine Health, Inc.)
11.3. Medtronic Plc.
11.4. Novartis International AG (Pear Therapeutics, Inc.)
11.5. Resmed, Inc. (Propeller Health)
11.6. Voluntis, Inc.
11.7. Ada Health GmbH
11.8. Cognifit ltd
11.9. Caterna Vision GmbH
11.10. Sonormed GmbH
11.11. Kaia Health
1.
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Report Title: Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline